Yuan A, Yang P C, Yu C J, Lee Y C, Yao Y T, Chen C L, Lee L N, Kuo S H, Luh K T
Department of Internal Medicine, National Taiwan University Hospital and Institute of Biomedical Sciences, Academia Sinica, Taipei, Republic of China.
Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2157-62. doi: 10.1164/ajrccm.152.6.8520790.
This study investigated the clinico-pathologic correlation of tumor angiogenesis in non-small-cell lung cancers. Formalin-fixed, paraffin-embedded surgical specimens of 55 consecutive patients with primary non-small-cell lung cancers were examined. Included were 26 squamous cell carcinomas and 29 adenocarcinomas. Twenty-five patients had stage I disease, eight patients had stage II disease, and 22 patients had stage IIIA or IIIB disease. Among them, 28 had nodal metastasis and 27 did not. The microvessel was demonstrated by immunocytochemical staining for factor VIII and platelet endothelial cell adhesion molecules (PECAM-1). The microvessels in the areas of highest neovascularization were counted under light microscopy in 200x field by two independent observers without knowledge of clinical information. At least three separate fields were counted for each specimen. The Mann-Whitney U test was used for statistical analysis. The microvessel counts in adenocarcinoma were significantly higher than in the squamous cell carcinoma (54.4 +/- 35.65 versus 26.16 +/- 20.46 in factor VIII staining and 80.52 +/- 48.42 versus 40.04 +/- 32.33 in PECAM-1 staining; p < 0.001). The microvessel counts in patients with Stages I-II disease were significantly lower than that of stages IIIA-IIIB disease (23.63 +/- 16.21 versus 65.36 +/- 31.92 in factor VIII staining and 41.85 +/- 36.76 versus 93.00 +/- 43.08 in PECAM-1; p < 0.001). Patients with nodal metastasis had higher microvessel density than those without nodal metastasis (56.67 +/- 35.55 versus 23.44 +/- 15.77 in factor VIII staining and 86.89 +/- 46.46 versus 36.30 +/- 25.83 in PECAM-1 staining; p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
本研究调查了非小细胞肺癌中肿瘤血管生成的临床病理相关性。对55例连续的原发性非小细胞肺癌患者的福尔马林固定、石蜡包埋手术标本进行了检查。其中包括26例鳞状细胞癌和29例腺癌。25例患者为I期疾病,8例患者为II期疾病,22例患者为IIIA期或IIIB期疾病。其中,28例有淋巴结转移,27例无淋巴结转移。通过因子VIII和血小板内皮细胞黏附分子(PECAM-1)的免疫细胞化学染色显示微血管。在200倍视野下,由两名独立观察者在不知道临床信息的情况下,对新生血管最丰富区域的微血管进行光镜计数。每个标本至少计数三个不同视野。采用曼-惠特尼U检验进行统计分析。腺癌中的微血管计数显著高于鳞状细胞癌(因子VIII染色分别为54.4±35.65与26.16±20.46,PECAM-1染色分别为80.52±48.42与40.04±32.33;p<0.001)。I-II期疾病患者的微血管计数显著低于IIIA-IIIB期疾病患者(因子VIII染色分别为23.63±16.21与65.36±31.92,PECAM-1染色分别为41.85±36.76与93.00±43.08;p<0.001)。有淋巴结转移的患者微血管密度高于无淋巴结转移的患者(因子VIII染色分别为56.67±35.55与23.44±15.77,PECAM-1染色分别为86.89±46.46与36.30±25.83;p<0.001)。(摘要截断于250字)